Tjalling Bosse

26PUBLICATIONS
108CO-AUTHORS
Social epidemiologyPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 19, 2026
Prognostic Relevance of Molecular Classification in Endometrial Cancer: Insights From a South African Cohort.

Rubina Razack, Ezgi Dicle Serbes, Michelle Cara Bryan-Mc Innes

|Jan 26, 2026
Evaluating a data-driven approach to biomarker discovery for tumor-targeted imaging in epithelial ovarian cancer.

Lysanne D A N de Muynck, Peter J K Kuppen, Eva M de Ronde

|Aug 23, 2025
Capturing breast cancers' copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond.

C J H Kramer, L M van Wijk, D Ruano

|May 05, 2025
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical data.

Lieke Lanjouw, Claire J H Kramer, Arja Ter Elst

|Oct 07, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.

Dione van Dijk, Lisa Vermij, Alicia León-Castillo

|Sep 03, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Anneke L Eerkens, Koen Brummel, Annegé Vledder

Pageof 5

Frequent Collaborators

7 joint publications

Claire Jh Kramer

7 joint publications

Nanda Horeweg

5 joint publications

Carien L Creutzberg

5 joint publications

Jan Jobsen